MoneyWorks4Me

Dr. Reddy’s Laboratories informs about newspaper advertisement

30 Jul 2022 Evaluate

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, Dr. Reddy’s Laboratories has informed that it enclosed copies of newspaper advertisement regarding the unaudited financial results of the company for the quarter ended June 30, 2022, as published in Business Standard and Andhra Prabha on July 28, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..